3d bio-printing

Organovo Holdings Inc (NASDAQ: ONVO) announced an exclusive distributor agreement with Cosmo Bio Co., Ltd. for its NovoView Preclinical Services in Japan, a day after it presented positive preclinical data of its 3D bio-printed human liver tissue when implanted into animal models. Organovo said it...